PCR TESTING MENUS

Cabot lab is a leading laboratory for Texas specializing in PCR. This leading method allows the accurate detection of slow-growing and non-culturable organisms that would be missed in traditional microbiology culture. Our innovative assay validation and intelligent reporting algorithms differentiate colonization from infection and suggest the best treatment options.

Our accurate detection of antimicrobial resistance genes contributes to antimicrobial stewardship efforts and reduces unnecessary antibiotic prescriptions. Our highly personalized workflows, supported by our laboratory and client service professionals, provide faster results through our simple yet robust result reporting.

 

Respiratory​​

Tier I with ABR

Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43

Human Bocavirus (HBoV)

Influenza A

Influenza B

Metapneumovirus

Parainfluenza Virus 1/2/3

Parainflunenza Virus 4

Respiratory Syncytial Virus A

Rhinovirus 1

Streptococcus pyogenes (Group A)

Pseudomonas aeruginosa

Staphylococcus aureus

Tier I ABRs

Carbapenemase and Metallo-beta-lactamase Resistance

Class A and C Beta-lactam Resistance

Class A and Plasmid ESBL Resistance

Class C Beta-lactam Resistance

Class D Beta-lactamase Resistance

Dihydrofolate and Sulfonamide Resistance

Macrolide Resistance

Methicillin Resistance

Quinolone Resistance

Vancomycin Resistance

  • Our accurate multi-pathogen molecular RPP avoids unnecessary antibiotic exposure in patients with viral diseases
  • We provide resistance testing for bacterial agents of respiratory infections
  • Respiratory infections can quickly turn devastating or fatal for individuals with antibiotic-resistant organisms, making accurate diagnostics pivotal to safe care

Urinary Tract Infection

Tier I with ABR

Acinetobacter baumannii

Aerococcus urinae

Candida group 1 (Candida albicans, C.tropicalis, C. parapsilosis, C. dubliniensis)

Candida group 2 (Candida auris, Candida glabrata)

Citrobacter freundii

Enterobacter aerogenes, Enterobacter cloacae

Enterococcus faecalis, Enterococcus faecium

Escherichia coli

Klebsiella oxytoca, Klebsiella pneumoniae

Morganella morganii

Proteus mirabilis, Proteus vulgaris

Providencia stuartii

Pseudomonas aeruginosa

Staphylococcus aureus

Staphylococcus saprophyticus

Streptococcus pneumoniae

Ureaplasma urealyticum, parvum

 

Tier I ABRs

Carbapenemase and Metallo-beta-lactamase Resistance

Class A and C Beta-lactam Resistance 

Class A and Plasmid ESBL Resistance

Class C Beta-lactam Resistance 

Class D Beta-lactamase Resistance

Dihydrofolate and Sulfonamide Resistance

Macrolide Resistance

Methicillin Resistance

Quinolone Resistance

Vancomycin Resistance

 

Tier II with ABR 

Candida krusei Staphylococci Coag-Neg (epidermidis, haemolyticus, lugdunensis) 

Streptococcus agalactiae (Group B) 

Streptococcus pyogenes (Group A) 

Viridans Streptococcus Group

 

Tier II ABRs

Macrolide Resistance

Methicillin Resistance

Vancomycin Resistance

  • Our innovative assay validation approach enables us to report actual CFU/mL values for bacteria using our PCR methodology while many molecular labs report inaccurate copy numbers of organisms
  • Our panel spans the detection of bacterial, fungal, and viral pathogens in one assay
  • In a traditional urine culture, only 57% of uropathogens can be detected whereas our molecular UTI panel detects >90% of these pathogens and their resistance markers
  • Our panel also detects UTI co-infections much more efficiently than standard urine culture
  • Our real-time PCR UTI panel delivers both identification and susceptibility results on the same day whereas culture-based methods take more than 72 hours

Sexually Transmitted Infection

Chlamydia trachomatis 

Gardnerella vaginalis 

Haemophilus ducreyi 

HSV1

HSV2 

Human papillomavirus type 16 

Human papillomavirus type 18, Human papillomavirus type 45

Human papillomavirus type (HPV 31, 33, 39) 

Human papillomavirus type (HPV 52, 59, 68) 

Mycoplasma genitalium, Mycoplasma hominis 

Neisseria gonorrhoeae 

Treponema pallidum 

Trichomonas vaginalis

 

ABRs

Macrolide Resistance

  • Aside from covering all major causative agents of STI, our panel also identifies and types high-risk HPV (16, 18, 31,33,39, 45, 52, 59, 68)

Women’s Health​

Atopobium vaginae, BVAB2, Mobiluncus curtisii, Mobiluncus mulieris

Candida krusei

Candida group 1 (Candida albicans, C.tropicalis, C. parapsilosis, C. dubliniensis)

Candida group 2 (Candida auris, Candida glabrata)

Chlamydia trachomatis

Gardnerella vaginalis

Haemophilus ducreyi

HSV1

HSV2

Human papillomavirus type 16

Human papillomavirus type 18, Human papillomavirus type 45

Human papillomavirus type (HPV 31, 33, 39)

Human papillomavirus type (HPV 52, 59, 68)

Megasphera 1, Megasphera 2

Mycoplasma genitalium, Mycoplasma hominis

Neisseria gonorrhoeae

Prevotella bivia

Streptococcus agalactiae (Group B)

Treponema pallidum

Trichomonas vaginalis

Ureaplasma urealyticum, parvum

Viridans Streptococcus Group

ABRs

Macrolide Resistance

  • We provide resistance testing for the bacterial pathogens included in our STI, BV, and Women’s Health panels.

Bacterial Vaginosis / Aerobic Vaginitis

Atopobium vaginae, BVAB2, Mobiluncus curtsii, Mobiluncus mulieris

Enterococcus faecalis, Enterococcus facecium

Escherichia coli

Gardnerella vaginalis

Megasphera 1, Megasphera 2

Staphylococcus aureus

Streptococcus agalactiae (Group B Strep)

ABRs

Carbapenemase and Metallo-beta-lactamase Resistance

Class A and C Beta-lactam Resistance

Class A and Plasmid ESBL Resistance

Class C Beta-lactam Resistance

Class D Beta-lactamase Resistance

Dihydrofolate and Sulfonamide Resistance

Methicillin Resistance

Quinolone Resistance

Vancomycin Resistance

  • Our panel gives an accurate view of bacterial vaginosis by enumerating causative agents of BV.
  • We accurately differentiate bacterial vaginosis from aerobic vaginitis
  • Molecular testing is significantly more sensitive than other methods for identification of BV, Candida species, and T. vaginalis.

Wound

Tier I with ABR

Acinetobacter baumannii

Bacteroides fragilis

Bartonella henselae

Candida krusei

Candida group 1 (Candida albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)

Candida group 2 (Candida auris, Candida glabrata)

Clostridium perfringens, Clostridium septicum

Corynebacterium striatum

Escherichia coli

Francisella tularensis

Finegoldia magna

Mycobacterium kansasii, Mycobacterium intracellulare

Nocardia asteroides

Pasteurella multocida

Peptoniphilus harei, Peptoniphilus ivorii

Peptostreptococcus spp

Pseudomonas aeruginosa

Staphylococci Coag-Neg (epidermidis, haemolyticus, lugdunensis)

Staphylococcus aureus

Streptococcus pneumoniae

Streptococcus pyogenes (Group A)

ABRs

Carbapenemase and Metallo-beta-lactamase Resistance

Class A and C Beta-lactam Resistance

Class A and Plasmid ESBL Resistance

Class C Beta-lactam Resistance

Class D Beta-lactamase Resistance

Dihydrofolate and Sulfonamide Resistance

Macrolide Resistance

Methicillin Resistance

Quinolone Resistance

Vancomycin Resistance

Tier II with ABR

Actinomyces israelii

Citrobacter freundii

Enterobacter aerogenes, Enterobacter cloacae

Enterococcus faecalis, Enterococcus faecium

Fusobacterium necrophorum, Fusobacterium nucleatum

Klebsiella oxytoca, Klebsiella pneumoniae

Malassezia furfur

Morganella morganii

Proteus mirabilis, Proteus vulgaris

Providencia stuartii

ABRs

Carbapenemase and Metallo-beta-lactamase Resistance

Class A and C Beta-lactam Resistance

Class A and Plasmid ESBL Resistance

Class C Beta-lactam Resistance

Class D Beta-lactamase Resistance

Quinolone Resistance

Vancomycin Resistance

  • Aside from covering the most common causative agents of wound infections, our wound panel also identifies organisms involved in animal bite infections and multi-drug resistant diabetic wound infections.
  • Our methodology accurately quantifies organisms present in a wound sample.
  • We provide resistance testing for bacterial wound infections.